Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Help & Advice
University of Warwick

The Library

  • Login
  • Admin

Guidelines for inclusion of patient-reported outcomes in clinical trial protocols : the SPIRIT-PRO extension

Tools
- Tools
+ Tools

Calvert, Melanie, Kyte, Derek, Mercieca-Bebber, Rebecca, Slade, Anita, Chan, An-Wen and King, Madeleine T. (2018) Guidelines for inclusion of patient-reported outcomes in clinical trial protocols : the SPIRIT-PRO extension. JAMA: The Journal of the American Medical Association, 319 (5). pp. 483-494. ISSN 0098-7484.

[img]
Preview
PDF
WRAP-guidelines-inclusion-patient-reported-outcomes-clinical-trial-protocols-2018.pdf - Accepted Version - Requires a PDF viewer.

Download (711Kb) | Preview
[img]
Preview
PDF
WRAP-supplementary-material1.pdf - Supplemental Material - Requires a PDF viewer.

Download (289Kb) | Preview
[img]
Preview
PDF
WRAP-supplementary-material2.pdf - Supplemental Material - Requires a PDF viewer.

Download (706Kb) | Preview
[img]
Preview
PDF
WRAP-supplementary-material3.pdf - Supplemental Material - Requires a PDF viewer.

Download (126Kb) | Preview
Official URL: https://doi.org/10.1001/jama.2017.21903

Request Changes to record.

Abstract

Importance:

Patient-reported outcome (PRO) data from clinical trials can provide valuable evidence to inform shared-decision making, labelling claims, clinical guidelines, and health policy; however, the PRO content of clinical trial protocols is often suboptimal. The SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) Statement was published in 2013 and aims to improve the completeness of trial protocols by providing evidence-based recommendations for the minimum set of items to be addressed, but does not provide PRO-specific guidance.

Objective

To develop international, consensus-based, PRO-specific protocol guidance: the SPIRIT-PRO extension.

Design, Setting, and Participants:

The SPIRIT-PRO Extension was developed following the Enhancing QUAlity and Transparency Of health Research (EQUATOR) Network’s methodological framework for guideline development. This included: (i) a systematic review of existing PRO-specific protocol guidance to generate a list of candidate PRO-specific protocol items (published 2014); (ii) refinements to the list and removal of duplicate items by the International Society for Quality of Life Research (ISOQOL) PROtocol Checklist Taskforce; (iii) an international stakeholder survey of: clinical trial research personnel, PRO methodologists, health economists, psychometricians, patient advocates, funders, industry representatives, journal editors, policy makers, ethicists and researchers responsible for evidence synthesis (distributed by 38 international partner organizations, October 2016); (iv) an international Delphi exercise (n=137 invited; October 2016 to February 2017)and consensus meeting (n=30 invited; May 2017). Prior to voting, consensus meeting participants were informed of the results of the Delphi exercise and given data from structured reviews evaluating the PRO protocol content of three defined samples of trial protocols.

Results:

The systematic review identified 162 PRO-specific protocol recommendations from 54 sources. The ISOQOL Taskforce (n=21) reduced this to 56 items, which were considered by 138 international stakeholders and 99 Delphi panelists. The final wording of the SPIRIT-PRO Extension was agreed at a consensus meeting (n=29 participants) and reviewed by external stakeholders during a consultation period. Eleven extensions and five elaborations to the SPIRIT 2013 checklist are recommended for inclusion in clinical trial protocols where PROs are a primary or key secondary outcome. Extension items focused on PRO specific issues relating to the: trial rationale, objectives, eligibility criteria, concepts used to evaluate the intervention, timepoints for assessment, PRO instrument selection and measurement properties, data collection plan, translation to other languages, proxy completion, strategies to minimise missing data and whether PRO data will be monitored during the study to inform clinical care.

Conclusions and relevance:

These guidelines provide recommendations for items that should be addressed and included in clinical trial protocols in which PROs are a primary or key secondary outcome. Improved design of clinical trials including PROs could help ensure high-quality data that may inform patient-centered care.

Item Type: Journal Article
Subjects: R Medicine > R Medicine (General)
Divisions: Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Health Sciences
Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Health Sciences > Social Science & Systems in Health (SSSH)
Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School
Library of Congress Subject Headings (LCSH): Clinical trials -- Methodology, Clinical trials -- Standards
Journal or Publication Title: JAMA: The Journal of the American Medical Association
Publisher: American Medical Association
ISSN: 0098-7484
Official Date: 6 February 2018
Dates:
DateEvent
6 February 2018Available
4 January 2018Accepted
Volume: 319
Number: 5
Page Range: pp. 483-494
Status: Peer Reviewed
Publication Status: Published
Access rights to Published version: Restricted or Subscription Access
Date of first compliant deposit: 7 February 2018
Date of first compliant Open Access: 6 August 2018
RIOXX Funder/Project Grant:
Project/Grant IDRIOXX Funder NameFunder ID
5592105Macmillan Cancer Supporthttp://dx.doi.org/10.13039/100011715
UNSPECIFIEDUniversity Of Birminghamhttp://dx.doi.org/10.13039/501100000855
UNSPECIFIEDCancer Australiahttp://dx.doi.org/10.13039/501100001111
ConDuCT-II Hub[MRC] Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
UNSPECIFIEDNational Institute for Health Researchhttp://dx.doi.org/10.13039/501100000272
UNSPECIFIEDJanssen-Cilaghttps://viaf.org/viaf/132798296
Contributors:
ContributionNameContributor ID
Research GroupThe SPIRIT-PRO Group, UNSPECIFIED
ResearcherDraper, Heather77828
ResearcherHaywood, Kirstie L.23784

Request changes or add full text files to a record

Repository staff actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics

twitter

Email us: wrap@warwick.ac.uk
Contact Details
About Us